Clinical examinations are a key component of all toxicology studies and are a major component of the functional observational battery (FOB). The FOB is a core feature of the USEPA neurotoxicity screening guideline of 1991.
tion. All toxicology laboratories conduct clinical examinations of animals on study, and Good Laboratory Practices of various countries and agencies require records of technician training. In addition, the USEPA neurotoxicity screening guidelines (USEPA, 1991) require that each laboratory provide "evidence of the ability of the observational methods used to detect major neurotoxic endpoints." If more than one person makes observations, then "some demonstration of interobserver reliability is required." Although the content of clinical examinations is left to individual laboratories, guidance was given in the USEPA neurotoxicity guideline on what constitutes an adequate set of functional observations (functional observational battery, FOB). No guidance, however, has been given on how to measure the quality of performance on clinical and FOB examinations, nor on how good the performance must be to be acceptable.
Although not stated clearly, it was presumed that the proficiency requirements applies to the individual (or individuals) conducting the FOB on a particular study, and not to the laboratory in general. The guideline also requires periodic redocumentation of proficiency at -1-year intervals (note 4, USEPA, 1991) .
To address the need for a measure of quality of performance, and to improve overall technician training and improve documentation of training (and performance), an objective performance standard and pass-fail criterion was developed for clinical and FOB examinations. Training is enhanced because training supervisors must define explicitly and a priori what should be seen across a wide variety of observations with each test drug, methods have to be carefully defined and be repeatable, and detailed communication to trainees is facilitated by pointto-point evaluation of their performance against the standard. The method uses FOB data generated within the laboratory, and thus each performance standard would be laboratory specific. The method, however, should have general application to other laboratories. Details on how to perform clinical examinations and FOBS per se are not presented since this information is available elsewhere (Moser, 1989; O'Donoghue, 1989; USEPA, 1991) .
METHODS

Overview
It has been stated (Tilson and Cabe, 1978 ) that a logical way to validate screening procedures is to use a battery of tests to compare agents having different neurotoxic profiles. To create different clinical profiles, pharmacologic agents were selected to cause distinctive but transient changes in several endpoints defined in the guideline while minimizing distress to the animals. The method requires the observer to make a series of observations according to the planned format ( Table l) , but the observer does not attempt to recognize a pattern or syndrome. After the data are collected, however, the aggregate of observations for a particular treatment group should create a profile or syndrome characteristic of that chemical ( Table 2 ). The point was not whether treated rats could be differentiated from control, but whether the collection of observations created a distinctive pattern. Other goals were to use as few animals as possible, to minimize discomfort by use of drugs to cause transient effects, to provide a wide range of "positive" observations, to test observers individually to avoid any opportunity for unintentional cueing from other observers, to create a clear criterion of success or failure, and to have a clear measure of interobserver reliability.
Clinical observations are a core feature of the FOB, which includes cage-side, hand-held, and open-field observations, body temperature, hindlimb and forelimb grip performance, and landing foot splay (Table 1) . For the evaluation of technician performance, the first step was to develop the performance standard, and the second step was to train and test technicians to meet or exceed the standard of performance. Proficiency training was a three-stage process, with the actual test of proficiency as the third stage: stage 1: familiarity with the technology and mechanics of the FOB; stage 2: positive effects training, through coaching, to recognize the physical and behavioral manifestations of saline and three pharmacologic agents; and stage 3 : proficiency test, without coaching, with the same pharmacologic agents. These data were used to make a comparison to the performance standard. 
Define the FOB and Describe Ranks
We have applied the concept of clinical profiles in the following method. The performance standard (the "expected" pattern of observations) was generated from FOB data from four experienced laboratory personnel. The FOB is a set of predetermined observations to be made on each animal ( Table 1) . After defining the content of the FOB, the next and one of the most important tasks is to describe clearly what constitutes an observation. The USEPA neurotoxicity screening guideline (1991) states, under Test Procedures (d)(7)(ii), that "explicit operationally defined scales for each measure are to be used," and under Data Reporting and Evaluation (e)(l)(i), that the report include "a detailed description of the procedures used to standardize observations, including the arena and scoring criteria."
In accordance to the guideline, each rank for ranked observations was carefully described. Generally, we used five ranks, from mild to severe or from none to a large amount. For example, muscle tone could range from "limp or flaccid" (rank 1) to "very tense or rigid" (rank 5). Categorical observations were present or absent (for example, tremors). Other elements of the FOB were measurements, such as grip performance or rectal temperature. After the FOB descriptions were completed, each experienced person performed FOBS on rats treated with saline or three different drugs.
Treatment Schedule
The animals were male Fischer 344 rats, 8-12 weeks old. The rats were treated with saline injection (control), chlorpromazine HCl (4 mgikg i.p., evaluated 15-20 min after injection), d-amphetamine (8 mg/kg i.p., evaluated 15-20 min after injection), and atropine-physostigmine (2 mgikg atropine i.p. followed in 5 min by 0.75 mg/kg physostigmine s.c., and evaluated 10-30 min after injection). The reason for atropine pretreatment of physostigmine-injected rats was to relieve the severe pulmonary distress that physostigmine alone sometimes caused.
Convert Incidence Data into Average Scores
Individual observations then were organized into an incidence summary table (Table 3 ). Incidence summary tables had observations from each rat entered by category (either a rat had the observation or it did not; for example, tremors), ranked observations (usually five levels, from none to exaggerated), and measurements (mean and SD). A key step to create a profile for each chemical was to simplify the incidence table such that each observation had one score to represent the treatment group (Table 4) . For ranked observations, the group score was the average rank of the group. For categorical observations ( + or -), the group score was the average incidence for the group (the number of rats with the observation divided by the group size). Scores for measurements (temperature, grip, and so on) were the group-mean value for that measurement.
Although most data points in the performance standard (Table 4 ) were a simple average of the scores for each observation from the four experienced observers, a few scores were modified slightly when it was felt one observer was particularly effective in recognizing a treatment effect. By subjectively weighting a couple of specific observational scores to that of a particularly effective observer, the performance standard was somewhat idealized.
Although data from all preplanned observations in Table 1 are presented, not all of these observations are used in the performance standard. A few of the Table 1 observations were not affected by any treatment and therefore did not add to a differentiating pattern of effects. Consequently, the performance standard as seen in Tables 2-4 are only those FOB observations that were affected by treatment. This selection of differentiating effects is important later, when technicians' scores are compared to the standard by Pearson's cross-correlation analysis. Inclusion of nondifferentiating features would artificially inflate the correlation coefficient.
List Average Scores in Sequence
To prepare the data for computation of Pearson's r, scores from the four pharmacologic syndromes were listed in sequence (again, categories not pertinent to the syndromes were not used). When scores for a set of treatments were listed in sequence, a complex sequence of numbers was created that was unique to the set of treatments. For example, for the four treatments, scores for the performance standard (Table 4 ) were muscle tone-3,2, 3.4,2; and extensor-thrust response-3, 2.4, 3.6, 2.6. These performance standard scores (in contiguous sets of four) were then listed as part of a sequence as . . . 3, 2, 3.4, 2, 3, 2.4, 3.6, 2.6, . . . tional categories were represented. Later, to test technician performance against the standard, the technician's scores from the four treatments will be cast into the same sequence. Although a Pearson's coefficient could be calculated at this time, the results would be quite insensitive to treatment effects because of the large baseline shift as shown in the baseline uncorrected portion of Fig. 1 .
"Baseline" Correction
The baseline needs to be removed to emphasize treatment-related differences between groups of animals. When a sequence of scores was represented as a line diagram (Fig. l) , a complex waveform was created. This complex waveform was unique to the scores generated from the four treatments, but the treatment-related elements "rode" on a baseline that was a function of the observation rather than of the treatment. The baseline has two components: (a) Each observation has an inherent level or intensity that is independent of treatment (tremors usually absent, and activity usually moderate). (b) Each technician will have a personal internal reference that, compared to someone else, leads to slightly higher or lower scores independent of treatment (one technician "sees" moderate activity, while another sees moderate verging on pronounced activity). Thus, while re- moval of the baseline emphasizes treatment-related differences in observations, it also removes non-treatment-related information on a technician's personal bias in reporting magnitude of effects. If, however, the technician overreports or underreports a treatment effect, this difference in reporting will be more apparent due to removal of the baseline. For example, if "muscle tone" of control rats was moderate, it would rate an average of 3. If the technician to be tested rated "muscle tone" of a treated group to be one rank lower (that is, a 2), we now had a I-point treatment-related difference in scores (3 vs 2). In a Pearson's calculation, this 1-point treatment-related difference was embedded in the scores of 3 and 2. The values of 3 and 2 were appreciably larger than the difference of 1, and consequently a Pearson's calculation would be strongly affected by the baseline and not sufficiently sensitive to the treatment-related difference (uncorrected portion of Fig. 1) .
The baseline was easily removed from each observation by taking an average of the four scores (one score per treatment) and subtracting this average from each of the four individual scores. For example, the average uncorrected score for "muscle tone" in the performance standard (Table 4) was (3 + 2 + 3.4 + 2)/4 = 2.6; the average value 2.6 was then subtracted from each score, with a new sequence of 0.4, -0.6, 0.8, and -0.6. This new sequence had a mean of zero (a zero baseline), and the numbers then reflected only the differences due to treatment. When observational scores, with a baseline of zero, were listed in se-quence, the pattern then appeared as in the corrected pattern in Fig. 1 . The baseline corrected scores are the final form of the performance standard.
Subsequently, each person to be tested would be tested individually on other treated rats and their set of observations would be organized the same as the standard, and Pearson's cross-correlation coefficient would be calculated. If the technician's pattern of observations were comparable to those expected (that is, the performance standard), then a high correlation would exist. Trainees go through three stages of training, and the third stage is the FOB examination of rats treated with drugs.
Stage I : Familiarity Training
Each trainee was introduced to the FOB technology and trained to use the necessary computers, conduct grip performance and hindlimb landing foot-splay tests, and take body temperatures. Technicians were required to become familiar with the specific ranked cage-side, hand-held, and open-field observations. Only stock, untreated rats were used for these activities. A minimum of 10 stock rats were observed. Technicians were allowed to progress to the next level of training when they understood the logistics of setting up for an FOB and demonstrated the ability to use the computers, handle the animals, collect rectal temperature, and perform the grip performance and landing foot-splay tests. Grip performance and landing foot-splay tests were considered satisfactory if the corresponding coefficients of variation were within the expected range (<25%). Training records reflected successful completion of this phase.
Stage 2: Positive Eflects Training with Pharmacologic Agents
With coaching, FOB technicians (blind to treatment group) observed and tested two or three rats per drug according to the same dosage and time schedule as just described for development of the performance standard. Coaching was not intensive, but was provided as necessary. The technician was permitted to proceed to stage 3 when the trainer was satisfied that the technician was making all of the expected observations. Training records reflected successful completion of this phase.
Stage 3: Proficiency Demonstration Against a Performance Standard
Without coaching, and blind to treatment, each technician performed an FOB on groups of rats treated with saline, chlorpromazine HC1, d-amphetamine sulfate, or atropine plus physostigmine sulfate. Doses and timing were the same as for the performance standard just described. The sample size was five rats per treatment group. The rats sometimes were treated more than once, but there was at least a 1-week interval between treatments. After injection, the rats were replaced into a numbered cage; the sequence for observation was random, and the technician did not know treatment status. The FOB instructor was present to treat rats, to tell the observer when a rat could be examined (proper timing for each drug), and for data entry, but did not coach nor participate in any way to making observations (the data-entry computer was several feet away from the observational area).
Proficiency was evaluated subjectively and objectively. Because observations were made one by one, blind to treatment, the technician had no specific pattern of observations in mind. The observations simply were collected as they occurred. Proficiency, however, required a demonstration that the observations, when assembled into single-score summary tables, created a pattern of observations that compared favorably with the laboratory performance standard.
Subjective Evaluation of Proficiency
The average-score summary data first were evaluated subjectively by the training personnel to see if the patterns of observations expected from saline, chlorpromazine, amphetamine, and atropine-physostigmine could be distinguished. The expected patterns are summarized in Table 2 .
Objective Evaluation of Proficiency
The pattern of observations was evaluated objectively by calculating a Pearson's cross-correlation coefficient between the performance standard and the scores generated by the technician (as organized for the performance standard). There were 14 differentiating observations per treatment, with 56 observations overall (4 treatments x 14 observations). Pearson's calculation was made via spreadsheet ( Table 5 ). Use of a spreadsheet allowed entry of uncorrected average performance standard scores and average technician scores, and an automatic baseline correction of the scores and calculation of the correlation coefficient. Due to the newness of this method of evaluating technicians, a rigid pass-fail criterion has not yet been established. Traditionally, r values > 0.8 have been regarded as high, although a statistically significant correlation occurs at r = 0.3-0.4, depending on the number of relevant observations used in the analysis (56 in this case). Clearly, a Pearson's r > 0.8 indicates a technician's ability to make observations that allow differentiation among complex pharmacologic syndromes.
Interobserver Reliability
To link interobserver reliability to the standard, reliability was evaluated by comparing the performance of two people against the same performance standard and against each other (Fig. 2 ). An r > 0.8 for all three correlations was considered satisfactory evidence of interobserver reliability and evidence of satisfactory overall performance.
ProJiciency at Measurements
Measurements of rectal temperature, forelimb and hindlimb grip performance, and landing foot splay were evaluated separately from hand-held and open-field observations. Personal technique tended not to be a problem for rectal temperature, but personal technique was important for the other measurements. Performance was considered satisfactory if the average coefficient of variation for con- Uncorrected average scores are from Table 4 for the performance standard and from Table 6 for the technician (D.A.M.). The baseline corrected scores sum to zero for each set of four. The Pearson's correlation is calculated from the corrected scores. The corrections and Pearson's r calculations were automatic within the spreadsheet. CPZ, chlorpromazine; d-Amp, d-amphetamine; and AtlPhy, atropine plus physostigmine. trols (saline) was <25% for each test. Coefficient of variation of -15% were considered very good. In addition, changes in the measurements were part of the pattern of events that created the syndrome that was characteristic of each drug treatment. Consequently, measurements were evaluated by Pearson's correlation in the same manner as observations, and the group mean of each measure was used. As with ranked and categorical data, it was necessary to correct the means for large baseline differences (for example, temperatures were -38"C, and splay was -3 cm). Thus, for temperatures for the four treatments, (38.4 + 37.2 + 39.5 + 37.2)/4 = 38.08, and each temperature minus 38.08 created the corrected scores of 0.32, -0.88, 1.42, -0.88. Table 6 to the expected pattern of findings in Table 2 shows that important categorical observations were appropriately made, Technician 1 FIG. 2. Technicians' performance compared to a performance standard and to each other. A Pearson's r was calculated for each combination. Correlations r , and rz were measures of performance, and r3 was a measure of interobserver reliability. Successful perfor-PERFORMANCE STANDARD qr3 mance was arbitrarily defined as r > 0.8.
RESULTS
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Technician 2
the average ranked observations fit the expected patterns, and the measurements were distributed as expected.
Objective evaluation of the data in Table 6 was by comparison to the performance standard. Figure 3 shows the complex pattern generated by baselinecorrected scores for the performance standard from 
Interobserver Reliability
Interobserver reliability was measured by comparing the performance of two people against the same performance standard and against each other (Fig. 2) . The Pearson's r for performance standard versus D.A. M. was 0.94 ( r , ) . For another technician (C.M.C.), the Pearson's rfor performance standard versus C.M.C. was 0.92 ( r 2 ) . Pearson's r for D.A.M. versus C.M.C. was 0.88 (rj). An r > 0.8 for all three correlations was considered satisfactory evidence of interobserver reliability and evidence of satisfactory overall performance for observations. For measurements, technician C.M.C. versus performance standard yielded r = 0.89, compared to r = 0.92 for observations. The measurement correlation between D.A.M. and C.M.C. was 0.89, which was very similar to their observational correlation. Using the criterion of r > 0.8, both technicians were considered competent at FOB measurements and were considered to have good interobserver reliability.
DISCUSSION
Several features of development of a performance standard were useful to laboratory supervisors. The first feature was required by the USEPA guideline (1991); the development of working definitions and descriptions of ranked differences for observations. The definitions required frequent interaction between supervisors and technicians to achieve finally a document that was understandable to all. Secondly, discussion of agents focused attention on what we really wanted technicians to recognize during clinical examinations. There were extensive discussions on which agent would create the most useful effects with the minimum of discomfort to the animals. In addition to the ethics of animal use, humaneness and value were essential if we were to have credibility with the technicians.
Both new and experienced laboratory personnel felt they benefited considerably by examining rats with such a diversity of clinical signs, and to be obliged to rank the severity or intensity of the behavior. All felt the level of discomfort of the animals was ethically acceptable considering the learning value of the exercise.
Although testing against a standard was done for purposes of documenting proficiency, laying out the results of the examinations from the four drug treatments, as in Fig. 3 , was unexpectedly effective for counseling. People could see the overall results of the examinations and could readily identify areas of high and low concordance with the standard. Remedial training, therefore, could be focused.
Records from objective measures of performance become part of the laboratory records, are submitted to the USEPA as required for support documents, meet training requirements of good laboratory practices, and are useful in personnel management for remedial work or for promotion.
Performance values beneath criterion (for example, r < 0.8) should, however, be interpreted carefully. The performance standard was developed on other animals at another time, and on the day of the technician's test the animals might have been different. Thus, the observations may have been accurate for the animals on that day. This problem is more likely if the dosed animals are older and have a history of more handling and previous dosing. However, our experience with 10 technicians indicates that the method is reasonably robust. To date, one technician has failed the criterion, and it was determined that more training was indeed necessary.
For interobserver reliability, all three r values ideally would be high and similar (rl = r2 = r3), indicating competency and excellent point-to-point interobserver comparability. One could encounter a high degree of agreement between technicians (r3 > 0.8), but each technician could have a somewhat low correlation to the performance standard (r, and r2 < 0.8). In this case, both technicians likely would have a systematic error in some of their observations. Although interobserver reliability was high, this should not be confused with a high quality of performance. One would not want either technician to perform observations on a study until performance was corrected.
An abstract by Sheets and Freshwater (1993) found the kappa statistic to be useful to evaluate interobserver reliability on USEPA neurotoxicity guideline studies. Personal communication with the author, however, indicated the method was difficult to implement and did not provide a single measure of performance. We did not explore the use of the kappa statistic because it did not address quality of performance, but only whether two observers performed similarly. It might be possible, however, to use the kappa statistic similarly to our use of Pearson's correlation (that is, examine all three relationships with the kappa statistic).
We did attempt to evaluate interobserver reliability with a special t test (Guilford and Fruchter, 1973) for the statistical significance of r , -r, (the difference between two individuals' correlations to a standard). This t test takes into account the correlation between the two observers (rj), and the expectation was that interobserver reliability could be evaluated directly in context with the performance standard. In operation, however, this special t test tended to punish highquality performance and reward poorer performance: that is, if r values were high, then small differences between observers were statistically significant; if Y values were lower, then the test was less sensitive to differences. Also, the test was sensitive to the number of observations; the more observations, the more sensitive the test. In sum, the special t test was not useful.
CONCLUSION
We concluded that this first attempt to measure the quality of performance of technicians objectively on clinical examinations and FOB was a step in the right direction. Obviously, improvements can and should be made; it is hoped others will expand or develop alternative methods that measure quality of performance more accurately and more efficiently.
